PURPOSE: The present treatment planning study compared whole breast radiotherapy (WBRT) to accelerated partial breast irradiation (APBI) for different external beam techniques and geometries (e.g., free breathing [FB] and deep inspiration breath hold [DIBH]). METHODS AND MATERIALS: After approval by our institutional review board, a treatment planning study was performed of 10 patients with left-sided Stage 0-I breast cancer enrolled in a Phase I-II study of APBI using intensity-modulated radiotherapy (IMRT). After lumpectomy, patients underwent planning computed tomography scans during FB and using an active breathing control device at DIBH. For the FB geometry, standard WBRT and three-dimensional conformal radiotherapy (3D-CRT) APBI plans were created. For the DIBH geometry with active breathing control, WBRT, 3D-CRT, and IMRT APBI plans were created. RESULTS: All APBI techniques had excellent planning target volume coverage. The maximal planning target volume dose was reduced from 116% of the prescription dose to 108% with the IMRT(DIBH) APBI plan. The maximal heart dose was >30 Gy for the WBRT techniques, 8.2 Gy for 3D-CRT(FB), and <5.0 Gy for 3D-CRT(DIBH) and IMRT(DIBH) techniques. The mean left anterior descending artery dose was significantly reduced from 11.4 Gy with WBRT(FB) to 4.2 with WBRT(DIBH) and <2.0 Gy with all APBI techniques. CONCLUSION: Although planning target volume coverage was acceptable with all techniques, the plans using the DIBH geometry resulted in a marked reduction in the normal tissue dose compared with WBRT planned in the absence of cardiac blocking. Additional study is needed to determine whether these techniques result in clinical benefits.
PURPOSE: The present treatment planning study compared whole breast radiotherapy (WBRT) to accelerated partial breast irradiation (APBI) for different external beam techniques and geometries (e.g., free breathing [FB] and deep inspiration breath hold [DIBH]). METHODS AND MATERIALS: After approval by our institutional review board, a treatment planning study was performed of 10 patients with left-sided Stage 0-I breast cancer enrolled in a Phase I-II study of APBI using intensity-modulated radiotherapy (IMRT). After lumpectomy, patients underwent planning computed tomography scans during FB and using an active breathing control device at DIBH. For the FB geometry, standard WBRT and three-dimensional conformal radiotherapy (3D-CRT) APBI plans were created. For the DIBH geometry with active breathing control, WBRT, 3D-CRT, and IMRT APBI plans were created. RESULTS: All APBI techniques had excellent planning target volume coverage. The maximal planning target volume dose was reduced from 116% of the prescription dose to 108% with the IMRT(DIBH) APBI plan. The maximal heart dose was >30 Gy for the WBRT techniques, 8.2 Gy for 3D-CRT(FB), and <5.0 Gy for 3D-CRT(DIBH) and IMRT(DIBH) techniques. The mean left anterior descending artery dose was significantly reduced from 11.4 Gy with WBRT(FB) to 4.2 with WBRT(DIBH) and <2.0 Gy with all APBI techniques. CONCLUSION: Although planning target volume coverage was acceptable with all techniques, the plans using the DIBH geometry resulted in a marked reduction in the normal tissue dose compared with WBRT planned in the absence of cardiac blocking. Additional study is needed to determine whether these techniques result in clinical benefits.
Authors: Robert C Frazier; Frank A Vicini; Michael B Sharpe; Di Yan; Julie Fayad; Kathy L Baglan; Larry L Kestin; Vincent M Remouchamps; Alvaro A Martinez; John W Wong Journal: Int J Radiat Oncol Biol Phys Date: 2004-03-15 Impact factor: 7.038
Authors: Jessica R Hiatt; Suzanne B Evans; Lori Lyn Price; Gene A Cardarelli; Thomas A Dipetrillo; David E Wazer Journal: Int J Radiat Oncol Biol Phys Date: 2006-08-01 Impact factor: 7.038
Authors: Silvia C Formenti; Minh Tam Truong; Judith D Goldberg; Vandana Mukhi; Barry Rosenstein; Daniel Roses; Richard Shapiro; Amber Guth; J Keith Dewyngaert Journal: Int J Radiat Oncol Biol Phys Date: 2004-10-01 Impact factor: 7.038
Authors: Katja M Langen; Daniel J Buchholz; Doug R Burch; Rob Burkavage; Arti U Limaye; Sanford L Meeks; Patrick A Kupelian; Kenneth J Ruchala; Jason Haimerl; Doug Henderson; Gustavo H Olivera Journal: Int J Radiat Oncol Biol Phys Date: 2008-01-22 Impact factor: 7.038
Authors: Jean M Moran; James M Balter; Merav A Ben-David; Robin B Marsh; Marcel Van Herk; Lori J Pierce Journal: Int J Radiat Oncol Biol Phys Date: 2007-06-01 Impact factor: 7.038
Authors: Frank A Vicini; Vincent Remouchamps; Michelle Wallace; Michael Sharpe; Julie Fayad; Laura Tyburski; Nicola Letts; Larry Kestin; Gregory Edmundson; Jane Pettinga; Neal S Goldstein; John Wong Journal: Int J Radiat Oncol Biol Phys Date: 2003-12-01 Impact factor: 7.038
Authors: Vincent M Remouchamps; Frank A Vicini; Michael B Sharpe; Larry L Kestin; Alvaro A Martinez; John W Wong Journal: Int J Radiat Oncol Biol Phys Date: 2003-02-01 Impact factor: 7.038
Authors: Kathy L Baglan; Michael B Sharpe; David Jaffray; Robert C Frazier; Julie Fayad; Larry L Kestin; Vincent Remouchamps; Alvaro A Martinez; John Wong; Frank A Vicini Journal: Int J Radiat Oncol Biol Phys Date: 2003-02-01 Impact factor: 7.038
Authors: Jacob S Witt; Robert W Gao; Lisa J Sudmeier; Stephen A Rosenberg; David M Francis; Charles R Wallace; Rupak K Das; Bethany M Anderson Journal: Brachytherapy Date: 2018-09-24 Impact factor: 2.362
Authors: Evan M Thomas; Richard A Popple; Brendan M Prendergast; Grant M Clark; Michael C Dobelbower; John B Fiveash Journal: J Appl Clin Med Phys Date: 2013-11-04 Impact factor: 2.102